Correlation Between Lyra Therapeutics and Prospector Capital
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Prospector Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Prospector Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Prospector Capital Corp, you can compare the effects of market volatilities on Lyra Therapeutics and Prospector Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Prospector Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Prospector Capital.
Diversification Opportunities for Lyra Therapeutics and Prospector Capital
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Lyra and Prospector is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Prospector Capital Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prospector Capital Corp and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Prospector Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prospector Capital Corp has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Prospector Capital go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Prospector Capital
If you would invest 1,056 in Prospector Capital Corp on August 25, 2024 and sell it today you would earn a total of 0.00 from holding Prospector Capital Corp or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 0.44% |
| Values | Daily Returns |
Lyra Therapeutics vs. Prospector Capital Corp
Performance |
| Timeline |
| Lyra Therapeutics |
| Prospector Capital Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lyra Therapeutics and Prospector Capital Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Prospector Capital
The main advantage of trading using opposite Lyra Therapeutics and Prospector Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Prospector Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prospector Capital will offset losses from the drop in Prospector Capital's long position.| Lyra Therapeutics vs. Eliem Therapeutics | Lyra Therapeutics vs. HCW Biologics | Lyra Therapeutics vs. Scpharmaceuticals | Lyra Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |